Your browser doesn't support javascript.
loading
Indicaciones del dabigatrán / Indications for dabigatran
Calvo Romero, J. M; Lima Rodríguez, E. M.
Affiliation
  • Calvo Romero, J. M; Hospital Ciudad de Coria. Cáceres. España
  • Lima Rodríguez, E. M; Centro de Salud de Montehermoso. Cáceres. España
Article in Spanish | IBECS | ID: ibc-88085
Responsible library: ES1.1
Localization: BNCS
RESUMEN
El dabigatrán es un nuevo inhibidor directo de la trombina de administración oral. Este artículo revisa los resultados de los principales ensayos clínicos que justifican las indicaciones actuales en la prevención de la enfermedad tromboembólica venosa en cirugía ortopédica de cadera y rodilla, la prevención de embolia en fibrilación auricular y el tratamiento de la enfermedad tromboembólica venosa (AU)
ABSTRACT
Dabigatran is a new oral direct thrombin inhibitor. This article reviews the results of major clinical trials to justify the present indications in the prevention of venous thromboembolic disease in knee and hip orthopaedic surgery, prevention of embolism in atrial fibrillation and treatment of venous thromboembolic disease (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Orthopedics / Atrial Fibrillation / Thrombin / Receptors, Thrombin / Embolism / Venous Thromboembolism / Anticoagulants Type of study: Etiology study / Risk factors Limits: Female / Humans / Male Language: Spanish Journal: SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.) Year: 2011 Document type: Article Institution/Affiliation country: Centro de Salud de Montehermoso/España / Hospital Ciudad de Coria/España
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Orthopedics / Atrial Fibrillation / Thrombin / Receptors, Thrombin / Embolism / Venous Thromboembolism / Anticoagulants Type of study: Etiology study / Risk factors Limits: Female / Humans / Male Language: Spanish Journal: SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.) Year: 2011 Document type: Article Institution/Affiliation country: Centro de Salud de Montehermoso/España / Hospital Ciudad de Coria/España
...